It has been reported that the down-regulation of p21 mediated by melanoma-associated antigen A12 (MAGEA12) may be involved in the pathogenesis of cSCC, which indicates that MAGEA12 might be a molecular biomarker of cSCC (9). Here, MAGEA12 is linked to skin squamous cell carcinoma.